Cambrex

Overview

Cambrex is a contract development and manufacturing organization (CDMO) based in the United States, specializing in the pharmaceutical manufacturing sector. Founded in 1981, the company employs between 1,001 and 5,000 individuals and reported revenue of approximately $717 million. Cambrex focuses on producing drug product materials for clinical trials, commercialized products, and over-the-counter (OTC) offerings. The company has integrated Environmental, Social, and Governance (ESG) programs into its operations, aligning these initiatives with corporate growth objectives such as cost reduction and enhanced employee productivity. Cambrex's sustainability roadmap emphasizes ethics, transparency, and responsible corporate citizenship, aiming to improve supply chain practices and reduce greenhouse gas emissions, particularly Scope 3 emissions, which are significant in the pharmaceutical industry's value chain. The company's ESG policies are overseen by its Board of Directors, reflecting a commitment to sustainability that supports both its operational goals and those of its customers. The focus on sustainability and operational efficiency positions Cambrex as a responsive partner in the evolving pharmaceutical manufacturing landscape.

Industry